Using role theory to explore pharmacist role conflict in opioid risks communication

Thakur, Tanvee; Chewning, Betty

doi:10.1016/j.sapharm.2019.11.012

Cited by 12 publications

(13 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A series of studies have examined and found differences between patient and HCP perceptions. 16 Parents reported wanting to know the medication prescribed for their child was an opioid when this had not been explained earlier. 16 , 17 In a study assessing communication and relationships between patients and providers, patients had variable opinions regarding HCP treatment decisions.…”

Section: Resultsmentioning

confidence: 99%

“… 16 Parents reported wanting to know the medication prescribed for their child was an opioid when this had not been explained earlier. 16 , 17 In a study assessing communication and relationships between patients and providers, patients had variable opinions regarding HCP treatment decisions. 18 In another study, patients reported being informed by HCP about common side effects of opioids, but not of any risks such as overdose and dependency.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Communication between patients and health care professionals about opioid medications

Thakur

Frey

Chewning

2021

Exploratory Research in Clinical and Social Pharmacy

Self Cite

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Communication between patients and health care professionals about opioid medications

Thakur

Frey

Chewning

2021

Exploratory Research in Clinical and Social Pharmacy

Self Cite

View full text Add to dashboard Cite

“…Pharmacists could provide such information but may be deterred by the sensitivity of risk and problematic use issues [ 28 ]. More training and professional development regarding communication about sensitive issues could overcome this reluctance [ 38 ].…”

Section: Discussionmentioning

confidence: 99%

Roles, barriers and behavioral determinants related to community pharmacists' involvement in optimizing opioid therapy for chronic pain: a qualitative study

2021

View full text Add to dashboard Cite

Background Opioid are currently widely used to manage chronic non-malignant pain (CNMP), but there is a growing concern about harm resulting from opioid misuse and the need for medicine optimization, in which pharmacists could potentially play a key role. Objective This study explored pharmacists' roles, barriers and determinants related to their involvement in optimizing prescribed opioids for patients with chronic pain. Setting Community pharmacies in the United Kingdom. Method Semi-structured interviews based on the Theoretical Domains Framework were conducted between January and May 2020 with 20 community pharmacists recruited through professional networks. Data were analysed thematically. Main outcome measure: Pharmacists’ perceived roles, barriers and behavioural determinants in relation to opioid therapy optimization. Result Pharmacists demonstrated desire to contribute to opioid therapy optimization. However, they described that they were often challenged by the lack of relevant knowledge, skills and training, inadequate time and resources, systemic constraints (such as lack of access to medical records and information about diagnosis), and other barriers including relationships with doctors and patients. Conclusion The contribution of community pharmacists to optimize opioid therapy in CNMP is unclear and impeded by lack of appropriate training and systemic constraints. There is a need to develop innovative practice models by addressing the barriers identified in this study to enhance the contribution of community pharmacists in optimization of opioid therapy for chronic pain.

show abstract

“…In spite of the significance of the regular communication between patients and community pharmacist in relation to COT and PO, most interviewees mentioned the lack of regular communication with patients as a barrier to greater involvement with prescribed opioids optimisation and COT. This may be attributed to the growing use of online and mail-order pharmacies, as well as disability or limited mobility preventing CNMP patients from visiting the pharmacy [31]. Therefore, interventions that target CNMP patients should consider mobility limitations.…”

Section: Discussionmentioning

confidence: 99%

“…Similarly, Thakur et al (2020) reported that most patients stated that they had not been told about opioids' possible risks and prescribers and patients agreed that pharmacists should provide such information, while the pharmacists perceived opioid risk and problematic use as sensitive issues that they avoided raising with patients. More training regarding communication about sensitive issues like opioids both for practising health professionals and professional development was deemed necessary [31].…”

Section: Discussionmentioning

confidence: 99%

Community Pharmacists' Roles in Optimising Opioids Therapy for Chronic Non-malignant Pain Patients: a Qualitative Study.

Aa¹,

Paudyal²,

Yahyouche³

2021

Preprint

View full text Add to dashboard Cite

Background: Opioids are currently widely used to manage chronic non-malignant pain, but there is a growing concern about harm resulting from opioid misuse, and the need for medicine optimisation, in which pharmacists could potentially play a key role.Objective: This study seeks to identify challenges to community pharmacists’ role in optimizing prescribed opioids for Chronic Non-Malignant Pain (CNMP).Setting: Community pharmacies in the UK.Method: Semi-structured interviews based on the Theoretical Domains Framework were conducted with 20 community pharmacists recruited through professional networks and analysed thematically.Result: Pharmacists perceive themselves as guardians of patients’ welfare and aspire to contribute to prescribed opioid optimisation. However, they are challenged by the lack of relevant training, inadequate time and resources, infrastructural and systemic constraints (such as repeat prescribing and prescription delivery services, lack of access to medical records and information about diagnosis), personal factors, including communication with doctors, and relationship with patients.Conclusion: The role of community pharmacists in optimising chronic opioid therapy is neither well-defined nor implemented in the UK. Utilisation of their potential skills and knowledge in this area requires an appropriate training curriculum, tackling the infrastructural and systemic constraints, support and resources to facilitate pharmacists’ engagement in patient monitoring and education. The findings in this study can contribute to inform policy makers with potentials to enhance pharmacists’ role in opioids therapy optimisation and, hence, ensure patients' safety when using prescribed opioids.

show abstract

Using role theory to explore pharmacist role conflict in opioid risks communication

Cited by 12 publications

References 42 publications

Communication between patients and health care professionals about opioid medications

Communication between patients and health care professionals about opioid medications

Roles, barriers and behavioral determinants related to community pharmacists' involvement in optimizing opioid therapy for chronic pain: a qualitative study

Community Pharmacists' Roles in Optimising Opioids Therapy for Chronic Non-malignant Pain Patients: a Qualitative Study.

Contact Info

Product

Resources

About